Rebecca A Horne, MD in Brookline, MA - Medicare Pediatrics

Rebecca A Horne, MD is a medicare enrolled "Pediatrics" physician in Brookline, Massachusetts. Her current practice location is 1180 Beacon St, Suite 4a, Brookline, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (617) 232-2915.

Rebecca A Horne is licensed to practice in Massachusetts (license number 245180) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1013175686.

Contact Information

	Rebecca A Horne, MD
	1180 Beacon St, Suite 4a, Brookline, MA 02446-3885
	(617) 232-2915
	Not Available

Physician's Profile

Full Name	Rebecca A Horne
Gender	Female
Speciality	Pediatrics
Location	1180 Beacon St, Brookline, Massachusetts
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1013175686
Provider Enumeration Date: 05/29/2008
Last Update Date: 01/17/2013

Medicare PECOS Information:

PECOS PAC ID: 3173761947
Enrollment ID: I20130606000407

Medical Identifiers

Medical identifiers for Rebecca A Horne such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013175686	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	245180 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rebecca A Horne is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Rebecca A Horne, MD 1180 Beacon St, Suite 4a, Brookline, MA 02446-3885 Ph: (617) 232-2915	Rebecca A Horne, MD 1180 Beacon St, Suite 4a, Brookline, MA 02446-3885 Ph: (617) 232-2915

News Archive

BioAlliance, Vestiq enter licensing agreement to commercialize Oravig in the US

BioAlliance Pharma SA, an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the execution of the licensing agreement with Vestiq Pharmaceuticals to commercialize Oravig in the United States for the treatment of oropharyngeal candidiasis in adults.

HemaQuest commences HQK-1004 global Phase 2 clinical trial in EBV-related malignancies

HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.

Breast cancer patients can benefit from new nanobodies

A new discovery published online in The FASEB Journal promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, called "Nanobody," proves effective in clinical trials, it would represent a significant advance for breast cancer drug therapy because some drugs are effective only in some people.

Researchers achieve positive results from a sustainable intervention in the primary care practice

German researchers from the Institutes for General Practice in Frankfurt / Main and Jena have achieved positive results from a sustainable intervention in the primary care practice (Annals of Internal Medicine, volume 151, number 6, Sep. 15, 2009).

Approval for FOSRENOL (lanthanum carbonate), which controls phosphate levels in renal dialysis patients

Sweden's MPA has today granted the first regulatory approval in the world for FOSRENOL (lanthanum carbonate), a non-calcium, non-aluminium phosphate binding medicine developed to control phosphate levels in renal dialysis patients. Sweden will now become the Reference Member State in the EU Mutual Recognition Procedure for FOSRENOL, and this is the first step in securing marketing approval throughout Europe. A submission has also been made by Shire to gain marketing approval for FOSRENOL in the United States.

Pediatrics Doctors in Brookline, MA

Dr. Sari Joan Rotter, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 637 Washington St, Suite 202, Brookline, MA 02446 Phone: 617-232-2811 Fax: 617-277-8180
Jennifer Allison Ross, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2 Brookline Pl, Brookline, MA 02445 Phone: 617-355-2727
Mary E Gordon, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Children's Hospital, 300 Longwood Ave, Brookline, MA 02115 Phone: 617-355-6000
Dr. Bruce Willard Bunnell, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: One Brookline Place, Suite 327 Centre Pediatric Associates Pc, Brookline, MA 02445 Phone: 617-735-8585 Fax: 617-232-0572
Jennifer M Lewis, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8 Penniman Rd, Brookline, MA 02445 Phone: 617-738-9001
Dr. Lisa Elaine Schnettler, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 28 James St Apt B, Brookline, MA 02446 Phone: 513-314-8052

Rebecca A Horne, MD - Medicare Pediatrics in Brookline, MA